Brief: Castle Biosciences Q1 Revenue USD 83.679 Million Vs. IBES Estimate USD 79.4 Million
06/05/2026 21:05
May 06 (Reuters) - Castle Biosciences Q1 operating expenses USD 102.086 million. Q1 operating income USD -18.407 million Q1 pretax profit USD -14.413 million Q1 net income USD -14.522 million Q1 basic EPS USD -0.49
Recent news on Castle Biosciences
See all newsU.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Castle Biosciences beats Q1 revenue estimates, raises FY revenue outlook
Brief: Castle Biosciences Q1 Revenue USD 83.679 Million Vs. IBES Estimate USD 79.4 Million
Castle Biosciences Q4 revenue beats expectations
Brief: Castle Biosciences Q4 Revenue USD 87.01 Million Vs. IBES Estimate USD 79 Million